期刊文献+
共找到10篇文章
< 1 >
每页显示 20 50 100
Fuelling and Diagnostics with Pellet Injection in the HL-1M Tokamak
1
作者 彭利林 曹建勇 +8 位作者 李波 李立 肖正贵 郑银甲 李承跃 崔正英 邓柏权 严建成 袁涛 《Plasma Science and Technology》 SCIE EI CAS CSCD 2005年第6期3085-3091,共7页
The pellet injection experiments for fuelling and diagnostics have been carried out on the HL-1M tokamak. The eight-pellet injector was installed on HL-1M. A reliable monitordetector and camera system was set up to ta... The pellet injection experiments for fuelling and diagnostics have been carried out on the HL-1M tokamak. The eight-pellet injector was installed on HL-1M. A reliable monitordetector and camera system was set up to take initial pellet photographs and measure the initial pellet speed and size. High fuelling efficiency of 60 % - 100 % and a density profile with a peaking factor of 1.8 - 2.0 were obtained. The maximum density close to 10^14/cm^3 in HL-1M was achieved with newly optimized combined fuelling techniques. Two typical models of pellet ablation have been utilized for simulative calculation of the ablation rates in HL-1M. In comparison with the distribution of the measured Hα emission intensity from the digital data of the CCD camera, the experimental result seems more optimistic for core fuelling than theoretical predictions by the two models. The safety factor profile q(r) has been extracted from the information provided by the CCD camera during the pellet injection. The reliability of the measured results depends mainly on the calibration of the imaging space position. Based on the calibration, the measured q-profile becomes more reasonable than those published previously for the same shot number and same photograph. 展开更多
关键词 pellet injection core fuelling q - profile measurement CCD camera ablation simulation HL-1M tokamak
下载PDF
灯盏花素注射液治疗急性缺血性中风对血清sICAM-1的影响 被引量:1
2
作者 刘晓俊 高敏 +2 位作者 方穗雄 杨晓文 黄年斌 《中国中医急症》 2008年第4期476-477,486,共3页
目的探讨急性缺血性中风患者血清可溶性黏附分子(sICAM-1)的表达规律及灯盏花素治疗脑梗死的可能机制。方法将85例急性脑梗死患者随机分为灯盏花素治疗组和常规治疗对照组,分别检测脑梗死患者起病第1、4、7、14日时的sICAM-1浓度。结果... 目的探讨急性缺血性中风患者血清可溶性黏附分子(sICAM-1)的表达规律及灯盏花素治疗脑梗死的可能机制。方法将85例急性脑梗死患者随机分为灯盏花素治疗组和常规治疗对照组,分别检测脑梗死患者起病第1、4、7、14日时的sICAM-1浓度。结果入院后第4、7日灯盏花素治疗组患者血清sICAM-1浓度明显低于常规治疗对照组。结论灯盏花素注射液对缺血脑组织神经元保护作用的机制与其阻断白细胞与血管内皮细胞黏附、抑制ICAM-1表达、减轻脑缺血组织的炎症反应有关。 展开更多
关键词 急性脑梗死 血清可溶性黏附分子 灯盏花素注射液
下载PDF
血清TNF-β、sICAM-1、免疫黏附抑制因子与急性脑卒中合并肺部感染关系及对预后的影响 被引量:2
3
作者 李彬 李名燚 +1 位作者 谢雯 徐梅玲 《中国老年学杂志》 CAS 北大核心 2022年第14期3394-3397,共4页
目的探究血清肿瘤坏死因子(TNF)-β、可溶性细胞间黏附分子(sICAM)-1、免疫黏附抑制因子(FEIR)与急性脑卒中(AS)合并肺部感染关系及对预后的影响。方法选取AS患者138例,根据入院48 h内是否发生肺部感染分为合并肺部感染患者50例作为感... 目的探究血清肿瘤坏死因子(TNF)-β、可溶性细胞间黏附分子(sICAM)-1、免疫黏附抑制因子(FEIR)与急性脑卒中(AS)合并肺部感染关系及对预后的影响。方法选取AS患者138例,根据入院48 h内是否发生肺部感染分为合并肺部感染患者50例作为感染组、未合并肺部感染患者88例作为未感染组。检测对比两组血清TNF-β、sICAM-1、FEIR水平,分析各指标与AS合并肺部感染的关系。感染组根据随访3个月改良Rankin量表(MRS)评分分为预后良好组(20例)、预后不良组(30例)。比较不同预后患者血清TNF-β、sICAM-1、FEIR水平,Pearson相关性分析各指标与MRS评分相关性,并采用卡普兰-迈耶(K-M)曲线进行生存分析。结果感染组血清TNF-β、sICAM-1、FEIR水平显著高于未感染组(P<0.05);Logistic回归分析,血清TNF-β、sICAM-1、FEIR与AS合并肺部感染显著相关(P<0.05);预后不良组血清TNF-β、sICAM-1、FEIR水平显著高于预后良好组(P<0.05);Pearson相关性分析,血清TNF-β(r=-0.663)、sICAM-1(r=-0.481)、FEIR(r=-0.623)与MRS评分呈负相关(P<0.05);K-M曲线分析,随访3个月,血清TNF-β、sICAM-1、FEIR高表达者生存率显著低于低表达者(P<0.05)。结论血清TNF-β、sICAM-1、FEIR异常升高与AS合并肺部感染发生及预后情况密切相关,且有助于预测生存状况,为临床提供参考依据。 展开更多
关键词 急性脑卒中 肺部感染 肿瘤坏死因子-Β 可溶性细胞间黏附分子(sicam)-1 免疫黏附抑制因子(FEIR)
下载PDF
Melt Treatment of Al-7%Si Alloy by Flux Injection
4
作者 李沛勇 贾均 +1 位作者 郭景杰 陈玉勇 《Journal of Harbin Institute of Technology(New Series)》 EI CAS 1995年第4期67-70,共4页
MeltTreatmentofAl-7%SiAlloybyFluxInjectionLIPeiyong;JIAJun;GUOJingjie;CHENYuyong(李沛勇)(贾均)(郭景杰)(陈玉勇)(Dept.ofM... MeltTreatmentofAl-7%SiAlloybyFluxInjectionLIPeiyong;JIAJun;GUOJingjie;CHENYuyong(李沛勇)(贾均)(郭景杰)(陈玉勇)(Dept.ofMaterialScienceand... 展开更多
关键词 ss: MELT treatment A1-7%Si ALLOY FLUX injection
下载PDF
阿托伐汀对急性冠状动脉综合征患者血清可溶性细胞间黏附分子-1和可溶性血管细胞黏附分子-1的影响──附68例检测结果分析 被引量:5
5
作者 朱贵月 唐元升 +2 位作者 耿庆信 朱兴雷 张运 《新医学》 北大核心 2004年第12期722-724,共3页
目的 :观察早期应用阿托伐汀对急性冠状动脉综合征患者的可溶性细胞间黏附分子 1(solubleintercellularadhesionmolecules 1,sICAM 1)和可溶性血管细胞黏附分子 1(solublevascularcellad hesionmolecules 1,sVCAM 1)的影响 ,探讨阿托... 目的 :观察早期应用阿托伐汀对急性冠状动脉综合征患者的可溶性细胞间黏附分子 1(solubleintercellularadhesionmolecules 1,sICAM 1)和可溶性血管细胞黏附分子 1(solublevascularcellad hesionmolecules 1,sVCAM 1)的影响 ,探讨阿托伐汀降低急性冠状动脉综合征炎症反应的可能机制。方法 :稳定型心绞痛 30例 ,急性冠状动脉综合征 6 8例 ,后者再分为两亚组 :阿托伐汀组 35例 ,非阿托伐汀组 33例。用酶联免疫吸附法测定急性冠状动脉综合征患者入院后第 1、 3、 5、 7、 14日的sICAM 1和sVCAM 1水平 ,观察阿托伐汀对其sICAM 1和sVCAM 1水平的影响。结果 :急性冠状动脉综合征患者入院时血清sICAM 1和sVCAM 1水平均比稳定型心绞痛组明显增高 (P <0 0 1)。治疗后急性冠状动脉综合征两亚组的血清sICAM 1和sVCAM 1水平均有不同程度的降低 ,其中阿托伐汀组的下降更显著。结论 :阿托伐汀可以降低炎症反应 ,在急性冠状动脉综合征的早期治疗中起重要作用。 展开更多
关键词 急性冠状动脉综合征 患者 sicam1 可溶性细胞间黏附分子-1 可溶性血管细胞黏附分子-1 血清 入院 程度 目的 水平
下载PDF
老年多发性骨髓瘤患者血清增殖诱导配体、可溶性细胞间黏附分子-1、血小板生成素和血管内皮生长因子表达水平 被引量:8
6
作者 王欢 陈曦 +1 位作者 刘艳春 刘庆荣 《中国老年学杂志》 CAS CSCD 北大核心 2014年第22期6489-6491,共3页
多发性骨髓瘤主要特征是恶性变的细胞分泌大量单克隆免疫球蛋白。由于树突细胞是重要的抗原递呈细胞,在激发和控制获得性免疫反应的程度和范围中起重要的作用,也是免疫应答的起始细胞〔1,2〕,因此与其相关的蛋白,可能是促使骨髓瘤... 多发性骨髓瘤主要特征是恶性变的细胞分泌大量单克隆免疫球蛋白。由于树突细胞是重要的抗原递呈细胞,在激发和控制获得性免疫反应的程度和范围中起重要的作用,也是免疫应答的起始细胞〔1,2〕,因此与其相关的蛋白,可能是促使骨髓瘤发生和发展的因子〔3〕。血清增殖诱导配体( APRIL)、可溶性细胞间黏附分子(sICAM)-1、血小板生成素(TPO)和血管内皮生长因子( VEGF)均为此类相关蛋白,骨髓瘤患者四种蛋白血清表达升高〔4~7〕,四者对病变有一定促进作用。本文关注 A-PRIL、sICAM-1、TPO和VEGF在老年人多发性骨髓瘤中的表达及其相关性。 展开更多
关键词 多发性骨髓瘤 血清增殖诱导配体(APRIL) 可溶性细胞间黏附分子(sicam)-1 血小板生成素(TPO) 血管内皮生长因子(VEGF)
下载PDF
Geniposide, the component of the Chinese herbal formula Tongluojiunao, protects amyloid-β peptide(1–42)-mediated death of hippocampal neurons via the non-classical estrogen signaling pathway 被引量:3
7
作者 Jiao Li Feng Wang +11 位作者 Haimin Ding Chunyan Jin Jinyan Chen Yanan Zhao Xiaojing Li Wenju Chen Ping Sun Yan Tan Qi Zhang Xu Wang Angran Fan Qian Hua 《Neural Regeneration Research》 SCIE CAS CSCD 2014年第5期474-480,共7页
Tongluojiunao (TLJN) is an herbal medicine consisting of two main components, geniposide and ginsenoside Rg1. TLJN has been shown to protect primary cultured hippocampal neurons. How-ever, its mechanism of action re... Tongluojiunao (TLJN) is an herbal medicine consisting of two main components, geniposide and ginsenoside Rg1. TLJN has been shown to protect primary cultured hippocampal neurons. How-ever, its mechanism of action remains unclear. In the present study, primary cultured hippocampal neurons treated with Aβ1-42 (10 μmol/L) signiifcantly increased the release of lactate dehydroge-nase, which was markedly reduced by TLJN (2 μL/mL), speciifcally by the component geniposide (26 μmol/L), but not ginsenoside Rg1 (2.5 μmol/L). hTe estrogen receptor inhibitor, ICI182780 (1 μmol/L), did not block TLJN-or geniposide-mediated decrease of lactate dehydrogenase under Aβ1-42-exposed conditions. However, the phosphatidyl inositol 3-kinase or mitogen-activated protein kinase pathway inhibitor, LY294002 (50 μmol/L) or U0126 (10 μmol/L), respectively blo cked the decrease of lactate dehydrogenase mediated by TLJN or geniposide. hTerefore, these results suggest that the non-classical estrogen pathway (i.e., phosphatidyl inositol 3-kinase or mitogen-activated protein kinase) is involved in the neuroprotective effect of TLJN, speciifcally its component, geniposide, against Aβ1-42-mediated cell death in primary cultured hippocampal neurons. 展开更多
关键词 nerve regeneration neurodegeneration Alzheimer's disease cell culture hippocampus neurons 1-42 estrogen signaling pathway phosphatidyl inositol 3-kinase pathway mitogen-acti- vated protein kinase pathway Tongluojiunao injection GENIPOSIDE ginsenoside Rgl NSFC grant neural regeneration
下载PDF
Effect of Ligustrazine Injection on Levels of Interleukin-4 and Interferon-γin Patients with Bronchial Asthma 被引量:14
8
作者 车晓文 张颖 +1 位作者 王晖 王伟 《Chinese Journal of Integrative Medicine》 SCIE CAS 2008年第3期217-220,共4页
Objective: To explore the effect of ligustrazine injection (LI) on serum levels of interleukin-4 (IL-4) and interferon- -γ (IFN- -γ ) in patients with bronchial asthma and determine the mechanism of action of... Objective: To explore the effect of ligustrazine injection (LI) on serum levels of interleukin-4 (IL-4) and interferon- -γ (IFN- -γ ) in patients with bronchial asthma and determine the mechanism of action of LI in preventing and treating asthma. Methods: Sixty-eight patients with mild or moderate bronchial asthma were assigned to two groups equally according to their sequence number, odd or even. The conventional treatment was administered to both groups, and LI was given to the treatment group by ultrasonic spray inhalation twice a day but not to the control group. The therapeutic course for all was 2 weeks. Further, 30 healthy subjects who had no history of smoking were enrolled as the normal control group. The clinical condition scores, frequency of attacks and dosage of Terbutaline inhaled were scored and recorded on the first day of hospitalization (before treatment) and after treatment. At the same time, the indexes of lung function, including forced expiratory volume in one second (FEV1), forced expiratory volume in one second to forced vital capacity ratio (FEV1%) and the peak expiratory flow (PEF) were determined before treatment. The levels of IL-4 and IFN--γ in peripheral blood were detected by ELISA before and after treatment, and compared with that of the healthy control group. Results: After treatment, the clinical condition scores were found to be lower, indexes of lung function were elevated, but serum level of IL-4 and ratio of IL-4/IFN-γwere reduced in both groups, showing significant differences as compared to those before treatment (P〈0.05). However, the changes in all the indexes were more significant in the treatment group than in the control group, also showing statistical significance (P〈0.05). No significant difference was revealed when IFN--γ levels were compared before and after treatment in both groups, though a lowering trend could be seen, significant difference could not be found in the comparison of IFN--γ levels between groups after treatment (P〉0.05). Conclusion: LI shows good clinical effect in treating bronchial asthma, and its mechanism might be related to the suppression of the synthesis of IL-4, thus leading to the inhibition of TH2 cell subset preponderant response and immune equilibrium regulation. 展开更多
关键词 ligustrazine injection ASTHMA lung function TH1/Th2 disequilibrium INTERLEUKIN-4 interferon- -γ
原文传递
Protective effect of Xuebijing injection on myocardial injury in patients with sepsis: a randomized clinical trial 被引量:7
9
作者 Zhang Hongwei Wei Liyou +4 位作者 Zhao Gang Liu Shuzheng Zhang Zhenyu Zhang Jing Yang Yajing 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2016年第6期706-710,共5页
OBJECTIVE: To investigate the protective effect and possible mechanism of Xuebijing Injection on myocardial injury in patients with sepsis, and to evaluate its prognostic implications.METHODS: Patients with septic myo... OBJECTIVE: To investigate the protective effect and possible mechanism of Xuebijing Injection on myocardial injury in patients with sepsis, and to evaluate its prognostic implications.METHODS: Patients with septic myocardial injury were recruited, and were randomly divided into two groups: treatment group and control group. All patients in two groups received conventional cluster treatment, the patients in treatment group additional received Xuebijing injection dissolved in0.9% sodium chloride injection, and the patients in control group received the same amount of 0.9%sodium chloride injection. At the beginning of treatment and 3, 7 and 10-day after treatment, lab-oratory indicators of cardiac troponin Ⅰ(cTnI),N-terminal pro B-type natriuretic peptide(NT-pro BNP) and procalcitonin(PCT) were respectively tested in venous blood. The patient's length of stay in Intensive Care Unit(ICU) and the mortality in 28 days were recorded.RESULTS: At 3, 7 and 10-day after treatment, the improvements of c Tn I, NT-pro BNP and PCT in treatment group were better than those in control group, and the differences were statistically significant(P < 0.05). The mortality of treatment group in28 days was not significantly different from that of control group(P > 0.05). The ICU length of stay of treatment group was shorter than that of control group(P > 0.05).CONCLUSION: Xuebijing injection could improve the levels of c Tn I, NT-pro BNP and PCT in patients with septic myocardial injury.and it had a protective effect on myocardial injury. 展开更多
关键词 SEPSIS Myocardial reperfusion injury Cardiac troponin Pro-brain natriuretic peptide(1-76) PROCALCITONIN Randomized clinical trials Xuebijing injection
原文传递
Two new terpenoids from Reduning Injection 被引量:2
10
作者 Hai-bo Li Biao Yang +6 位作者 Wen Ge Ze-yu Cao Liang Cao Yang Yu Zhen-zhong Wang Xin-sheng Yao Wei Xiao 《Chinese Herbal Medicines》 CAS 2020年第2期183-187,共5页
Objective:To study the antipyretic and anti-inflammatory constituents from the active fraction of Reduning(RDN)Injection.Methods:In this study,the active fraction of RDN Injection was screened by the LPS-induced mouse... Objective:To study the antipyretic and anti-inflammatory constituents from the active fraction of Reduning(RDN)Injection.Methods:In this study,the active fraction of RDN Injection was screened by the LPS-induced mouse endotoxin shock model.The chemical constituents were isolated by chromatography on HP-20 macroporous adsorptive resins,silica gel,ODS columns and reverse phase MPLC and HPLC repeatedly,and their structures were elucidated based on spectroscopic analysis(HR-ESI-MS,NMR,ECD)and chemical methods.Meanwhile,we evaluated the anti-inflammatory activities of the isolates by measuring their inhibitory effects on TNF-αproduction in LPS stimulated RAW 264.7 macrophages.Results:The 95%ethanol eluate of RDN Injection by the macroporous adsorption resin column was proved to be the antipyretic and anti-inflammatory active fraction of this injection.A novel iridoid,named jasminoide A(1),and a new guaiane sesquiterpenoid,named(1 R,7 R,8 S,10 R)-7,8,11-trihydroxy-4-guaien-3-one(2),were isolated from Reduning injection,and compound 2 can inhibit TNF-αproduction with IC50 values of 72.24μmol/L.Conclusion:In this study,two new terpenoids were isolated from Reduning Injection,and compound 2 showed inhibitory activity against LPS-activated TNF-αproduction in RAW 264.7 cells in vitro. 展开更多
关键词 (1R 7R 8S 10R)-7 8 11-trihydroxy-4-guaien-3-one ANTI-INFLAMMATION jasminoide A Reduning injection TNF-Α
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部